1. Home
  2. ETNB vs FIP Comparison

ETNB vs FIP Comparison

Compare ETNB & FIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • FIP
  • Stock Information
  • Founded
  • ETNB 2018
  • FIP 2021
  • Country
  • ETNB United States
  • FIP United States
  • Employees
  • ETNB N/A
  • FIP N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • FIP Consumer Electronics/Appliances
  • Sector
  • ETNB Health Care
  • FIP Industrials
  • Exchange
  • ETNB Nasdaq
  • FIP Nasdaq
  • Market Cap
  • ETNB 867.4M
  • FIP 1.0B
  • IPO Year
  • ETNB 2019
  • FIP N/A
  • Fundamental
  • Price
  • ETNB $8.04
  • FIP $7.82
  • Analyst Decision
  • ETNB Buy
  • FIP Strong Buy
  • Analyst Count
  • ETNB 7
  • FIP 2
  • Target Price
  • ETNB $30.33
  • FIP $11.50
  • AVG Volume (30 Days)
  • ETNB 800.5K
  • FIP 1.1M
  • Earning Date
  • ETNB 11-07-2024
  • FIP 10-30-2024
  • Dividend Yield
  • ETNB N/A
  • FIP 1.51%
  • EPS Growth
  • ETNB N/A
  • FIP N/A
  • EPS
  • ETNB N/A
  • FIP N/A
  • Revenue
  • ETNB N/A
  • FIP $332,173,000.00
  • Revenue This Year
  • ETNB N/A
  • FIP $9.44
  • Revenue Next Year
  • ETNB N/A
  • FIP $26.93
  • P/E Ratio
  • ETNB N/A
  • FIP N/A
  • Revenue Growth
  • ETNB N/A
  • FIP 7.01
  • 52 Week Low
  • ETNB $7.00
  • FIP $3.42
  • 52 Week High
  • ETNB $16.63
  • FIP $10.46
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 44.02
  • FIP 38.72
  • Support Level
  • ETNB $7.44
  • FIP $7.50
  • Resistance Level
  • ETNB $8.09
  • FIP $8.55
  • Average True Range (ATR)
  • ETNB 0.44
  • FIP 0.36
  • MACD
  • ETNB -0.06
  • FIP -0.05
  • Stochastic Oscillator
  • ETNB 22.47
  • FIP 33.78

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About FIP FTAI Infrastructure Inc.

FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.

Share on Social Networks: